Automated chromatin profiling with spa-ChIP-seq uncovers the impacts of condition variations
- Yuwei Cao1,2,
- Lauren Patel1,3,
- Lauren Alcoser4,
- Eric Mendenhall5,
- Christopher Benner6,
- Sven Heinz6 and
- Alon Goren1
- 1Department of Medicine, Division of Genomics & Precision Medicine, University of California San Diego, La Jolla, California 92093, USA;
- 2Bioinformatics and Systems Biology Graduate Program, University of California San Diego, La Jolla, California 92093, USA;
- 3Department of Bioengineering, Jacobs School of Engineering, University of California San Diego, La Jolla, California 92093, USA;
- 4Agilent Technologies, Santa Clara, California 95051, USA;
- 5HudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA;
- 6Department of Medicine, Division of Endocrinology & Metabolism, University of California San Diego, La Jolla, California 92093, USA
Abstract
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is widely used to study the genomic localization of DNA-associated proteins. However, conventional protocols include multiple manual steps that can introduce inconsistency and limit scalability, thereby restricting the inclusion of appropriate replicates and controls. Although the introduction of liquid handling platforms has improved reproducibility, most existing efforts have automated only a subset of the workflow, and extending automation to efficiently map nonhistone proteins, such as chromatin regulators, remains challenging. Here, we present a fully automated implementation of our previously developed single-pot ChIP-seq protocol, named spa-ChIP-seq, which enables scalable processing of eight to 96 ChIP-seq samples from cross-linked cells to a sequencing-ready library in approximately 3 days with an estimated cost of $70 per sample. Benchmarking spa-ChIP-seq against manual ChIP-seq performed in parallel demonstrates a comparable signal-to-noise ratio between the two workflows. Using spa-ChIP-seq, we systematically evaluate multiple parameters including shearing and cross-linking conditions, buffer compositions, and the ratio of antibody to cell number. We find, for the first time to our knowledge, that weaker genomic localization signals are sensitive to changing the antibody–to–cell-number ratio, whereas the stronger signals remain unaffected. This finding underscores the importance of maintaining consistent antibody–to–cell-number ratio for comparative studies, such as treatment responses or chromatin-QTL mapping. The spa-ChIP-seq protocol is publicly available, including deck setups, operational parameters, and scripts. We envision that this robust, cost-efficient protocol will facilitate high-throughput, reproducible ChIP-seq analyses, supporting large-scale studies of antibody validation, compound screening, population genomics, and diagnostic frameworks.
Footnotes
-
[Supplemental material is available for this article.]
-
Article published online before print. Article, supplemental material, and publication date are at https://www.genome.org/cgi/doi/10.1101/gr.281320.125.
- Received August 14, 2025.
- Accepted November 5, 2025.
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see https://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.











